Relief of symptoms and quality of life after conservative versus surgical treatment of benign liver tumors (CONSULT): a retrospective propensity score matched study

被引:1
作者
Furumaya, Alicia [1 ,2 ,9 ]
van Rosmalen, Belle V. [1 ,2 ]
de Graeff, Jan Jaap [1 ,2 ]
van der Poel, Marcel J. [1 ,2 ]
Ramsoekh, D. Sandjai [2 ,3 ]
Kazemier, Geert [4 ,5 ]
Verheij, Joanne [2 ,6 ]
Takkenberg, R. Bart [2 ,7 ]
Besselink, Marc G. [1 ,2 ]
Erdmann, Joris I. [1 ,2 ,8 ]
van Gulik, Thomas M. [1 ,2 ]
机构
[1] Amsterdam UMC Locat Univ Amsterdam, Dept Surg, Amsterdam, Netherlands
[2] Amsterdam Gastroenterol Endocrinol Metab, Amsterdam, Netherlands
[3] Amsterdam UMC Locat Vrije Univ Amsterdam, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[4] Amsterdam UMC Locat Vrije Univ Amsterdam, Dept Surg, Amsterdam, Netherlands
[5] Canc Ctr Amsterdam, Amsterdam, Netherlands
[6] Amsterdam UMC Locat Univ Amsterdam, Dept Pathol, Amsterdam, Netherlands
[7] Amsterdam UMC Locat Univ Amsterdam, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[8] Amsterdam UMC Univ Amsterdam, Dept Surg, Amsterdam Gastroenterol Endocrinol Metab, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands
[9] Univ Amsterdam, Dept Surg, Amsterdam UMC, Amsterdam, Netherlands
关键词
FOCAL NODULAR HYPERPLASIA; HEPATOCELLULAR ADENOMA; HEPATIC-TUMORS; RISK-FACTORS; MANAGEMENT; RESECTION; OUTCOMES; SURGERY; CLASSIFICATION; HEMANGIOMAS;
D O I
10.1016/j.hpb.2023.02.019
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Surgery can be considered for selected patients with benign liver tumours (BLT). The aim of this study was to compare symptoms and quality of life (QoL) after conservative and surgical man-agement of BLT.Methods: In this dual-site cross-sectional retrospective study, adult patients with BLT diagnosed be-tween 2000 and 2019 completed EORTC QLQ-C30 questionnaires on current symptoms and symptoms at diagnosis. Summary scores (SumScores) and QoL scores at follow-up were compared between surgically and conservatively treated patients by matched t-tests. Propensity score matching attempted to reduce confounding. Higher scores indicate less symptoms and higher QoL.Results: Fifty surgically (22.6%) and 171 (77.4%) conservatively treated patients were included at median 95 (IQR:66-120) and 91 (IQR:52-129) months, respectively. Most surgically treated patients reported stable, improved or disappeared symptoms (87%) and would undergo surgery again (94%). After propensity score matching, surgical patients had higher SumScores (mean difference 9.2, 95% CI:1.0-17.4, p = 0.028) but not higher QoL scores (p = 0.331) at follow-up than conservatively treated counterparts (31 patients in both groups).Discussion: Patients who had undergone surgery often reported they would undergo surgery again. Moreover, they had less symptoms than conservatively managed patients while they were propensity score matched on relevant variables, including baseline symptoms.
引用
收藏
页码:711 / 720
页数:10
相关论文
共 35 条
  • [1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [2] Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
    Austin, Peter C.
    [J]. STATISTICS IN MEDICINE, 2009, 28 (25) : 3083 - 3107
  • [3] Outcomes of liver resection in hepatocellular adenoma and focal nodular hyperplasia
    Bieze, Matthanja
    Busch, Olivier R. C.
    Tanis, Pieter J.
    Verheij, Joanne
    Phoa, Saffire S. K. S.
    Gouma, Dirk J.
    van Gulik, Thomas M.
    [J]. HPB, 2014, 16 (02) : 140 - 149
  • [4] Immunohistochemical Markers on Needle Biopsies Are Helpful for the Diagnosis of Focal Nodular Hyperplasia and Hepatocellular Adenoma Subtypes
    Bioulac-Sage, Paulette
    Cubel, Gaelle
    Taouji, Said
    Scoazec, Jean-Yves
    Leteurtre, Emmanuelle
    Paradis, Valerie
    Sturm, Nathalie
    Jeanne Tran Van Nhieu
    Wendum, Dominique
    Bancel, Brigitte
    Ramos, Jeanne
    Paraf, Francois
    Saint Paul, Marie Christine
    Michalak, Sophie
    Fabre, Monique
    Guettier, Catherine
    Le Bail, Brigitte
    Zucman-Rossi, Jessica
    Balabaud, Charles
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (11) : 1691 - 1699
  • [5] Measuring Change in Quality of Life: Bias in Prospective and Retrospective Evaluation
    Blome, Christine
    Augustin, Matthias
    [J]. VALUE IN HEALTH, 2015, 18 (01) : 110 - 115
  • [6] Surgical management of hepatocellular adenoma: Take it or leave it?
    Cho, Sung W.
    Marsh, J. Wallis
    Steel, Jennifer
    Holloway, Shane E.
    Heckman, Jason T.
    Ochoa, Erin R.
    Geller, David A.
    Gamblin, T. Clark
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (10) : 2795 - 2803
  • [7] EASL Clinical Practice Guidelines on the management of benign liver tumours
    Colombo, Massimo
    Forner, Alejandro
    Ijzermans, Jan
    Paradis, Valerie
    Reeves, Helen
    Vilgrain, Valerie
    Zucman-Rossi, Jessica
    [J]. JOURNAL OF HEPATOLOGY, 2016, 65 (02) : 386 - 398
  • [8] Liver Cell Adenoma: A Multicenter Analysis of Risk Factors for Rupture and Malignancy
    Deneve, Jeremiah L.
    Pawlik, Timothy M.
    Cunningham, Steve
    Clary, Bryan
    Reddy, Srinevas
    Scoggins, Charles R.
    Martin, Robert C. G.
    D'Angelica, Michael
    Staley, Charles A.
    Choti, Michael A.
    Jarnagin, William R.
    Schulick, Richard D.
    Kooby, David A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (03) : 640 - 648
  • [9] Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
    Dindo, D
    Demartines, N
    Clavien, PA
    [J]. ANNALS OF SURGERY, 2004, 240 (02) : 205 - 213
  • [10] Will weight loss become a future treatment of hepatocellular adenomain obese patients?
    Dokmak, Safi
    Belghiti, Jacques
    [J]. LIVER INTERNATIONAL, 2015, 35 (10) : 2228 - 2232